LATEST

• REGULATORY Japan Provides Stockpiled Avigan to UK for Hantavirus Prevention
  May 19, 2026

• REGULATORY 800 More Entities Seek War-Tied Supply Consultation as Future Anxiety Spreads
  May 19, 2026

• BUSINESS Asahi Kasei Starts Japan PIII of Extended Teribone Dosing
  May 19, 2026

• BUSINESS Allergan Files Botox Vista for Forehead Wrinkles
  May 19, 2026

• BUSINESS Stella Begins Japan PIII of BNCT for Recurrent Glioblastoma
  May 19, 2026

• BUSINESS Enhertu Earns 2 US Approvals in HER2-Positive Early Breast Cancer
  May 19, 2026

• REGULATORY Japan to Swiftly Consider Safety Measures over Tavneos: Minister
  May 19, 2026

• REGULATORY Japan Gives Orphan Tag to Revolution’s Pancreatic Cancer Drug, Others
  May 19, 2026

• REGULATORY Wegovy’s MASH Label Expansion and More Up for Japan Panel Review on May 29
  May 18, 2026

• BUSINESS Kissei Urges Halt to New Tavneos Use after Fatal Liver Injury Reports
  May 18, 2026

• REGULATORY Japan Eyes June Submission of Immunization Act Bill to Cover Antibody Drugs
  May 18, 2026

• BUSINESS Eisai Hits Record Sales as Leqembi Revenue Nearly Doubles in FY2025
  May 18, 2026

• REGULATORY Calls Grow for Japan Version of EHDS at Regulatory Reform Panel
  May 18, 2026

• BUSINESS Kaken Files Vascular Malformation Drug in Japan, Eyes FY2027 Approval
  May 18, 2026

• ORGANIZATION Patient Group Pushes Emergency Steps to Address Concerta Supply Imbalances
  May 18, 2026

• BUSINESS Regenxbio Appeals FDA CRL for MPS II Gene Therapy RGX-121
  May 18, 2026

• BUSINESS Fuji Sees New Bio-AG Pricing Rules as Tailwind for Biosimilars
  May 18, 2026

• BUSINESS Astellas’ Izervay Accepted for Review in China for AMD
  May 18, 2026

• BUSINESS Espha to Reinvest AG Profits into New Biz after Reform; Xarelto AG Logs 19 Billion Yen
  May 15, 2026

• BUSINESS Meiji Opposes French Fund’s Push to Review Pharma Spin-Off
  May 15, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• Next ›
• 最終 »